Serial #79426904
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79426904 Trademark

Serial Number: 79426904

Serial #79426904 is a trademark filed by Guangzhou Youmi Biotechnology Co., Ltd on April 1, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Guangzhou Youmi Biotechnology Co., Ltd

Room 409, Building A,

Entity Type: 03

Trademark Details

Filing Date

April 1, 2025

Registration Date

Not Registered

Published for Opposition

June 23, 2026

Goods & Services

Chemico-pharmaceutical preparations for skin care; vaginal washes for medical purposes; balms for medical purposes; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; antiseptics; analgesics; acne treatment preparations; medicinal oils, other than essential oils; Skin lotions for pharmaceutical purposes; medicinal drinks

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 23, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 23, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 17, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 27, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 27, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
May 27, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
May 27, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 27, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 1, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 1, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 1, 2026 TROA
REFUSAL PROCESSED BY IB
Nov 22, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 30, 2025 RFCS
REFUSAL PROCESSED BY MPU
Oct 30, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 12, 2025 RFCR
NON-FINAL ACTION WRITTEN
Sep 11, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 28, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 14, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 14, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 3, 2025 REPR